News
Important Regulatory Milestone achieved for Immunetune’s NeoVAC platform
Immunetune is proud to announce that they can continue their regulatory pathway, following supportive Scientific Advice from the Paul-Ehrlich Institute (PEI) in Germany on the 18th of June 2020. “The overall positive feedback received from the renowned...
Biotechgate Digital Partnering 31 Aug – 3 Sep 2020
Roger Legtenberg, CBO of Immunetune, will attend the Biotechgate Digital Partnering event on 31 Aug - 3 Sep, 2020. Feel free to request a meeting if you’d like to hear more about possible partnering or investment...
Immunetune joins the fight against Sars-CoV-2
Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell...
Biotechgate Digital Partnering 31 Aug – 3 Sep 2020
Roger Legtenberg, CBO of Immunetune, will attend the Biotechgate Digital Partnering event on 31 Aug - 3 Sep, 2020. Feel free to request a meeting if you’d like to hear more about possible partnering or investment...
Immunetune joins the fight against Sars-CoV-2
Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell...
Immunetune featured as one of the #DutchTechHeroes Fighting COVID-19
We're proud to be featured as one of the 200 companies in the overview: #DutchTechHeroes Fighting COVID-19. It is more important than ever that we empower & accelerate the tech companies that help us fight this pandemic. Find out more here by @TechLeapNL.
Finalist RESI Innovation Challenge
Immunetune is proud to have been selected as a finalist for the 2020 RESI Innovation Challenge! We will be presenting on the 23rd of March 2020 at the RESI 2020 Europe Conference in Paris.